TIPE3 and cholangiocarcinoma: Among these, TNFAIP8L3 was significantly upregulated in kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), cholangiocarcinoma (CHOL), and liver hepatocellular carcinoma (LIHC) tumor tissues (Figure 5A).